期刊文献+

cTnT、CA125及sST2在心力衰竭诊断及预后评估中的应用 被引量:3

Application of cTnT,CA125 and sST2 in diagnosis and prognosis of heart failure
下载PDF
导出
摘要 目的探讨心肌肌钙蛋白T(cTnT)、癌抗原125(CA125)及可溶性ST2蛋白(sST2)在心力衰竭诊断及预后评估中的应用价值。方法选择该院2015年8月至2017年1月收治的56例心力衰竭患者,设为研究组,另选取同期在该院体检健康者55例,设为对照组,两者均检测cTnT、CA125及sST2,分析检测结果。结果研究组cTnT、CA125及sST2均较对照组高,差异有统计学意义(P<0.05),研究组cTnT、CA125及sST2水平与患者心功能及其预后水平呈正相关(P<0.05),患者心功能分级越高,cTnT、CA125及sST2水平越高;存在心脏事件的患者cTnT、CA125及sST2水平高于不存在心脏事件者(P<0.05)。结论血清cTnT、CA125及sST2水平与心力衰竭病变程度密切相关,检测三者可有效反映病变情况,是诊断、评估心力衰竭病情的有效指标。 Objective To explore the application value of cTnT,CA125 and sST2 in the diagnosis and prognosis of heart failure. Methods Totally 56 patients with heart failure admitted from August 2015 to January 2017 were selected as research group,and 55 cases of healthy persons in the same period were selected as control group.Both of them detected cTnT,CA125 and sST2,and analyzed the results. Results The cTnT,CA125 and sST2 in the study group were higher than those in the control group ( P 〈0.05),the levels of cTnT,CA125 and sST2 were positively correlated with heart function and prognosis ( P 〈0.05).The higher the level of heart function,the higher the level of cTnT,CA125 and sST2,and the levels of cTnT,CA125 and sST2 in patients with heart events were higher than those without heart events ( P 〈0.05). Conclusion The level of serum cTnT,CA125 and sST2 is closely related to the degree of heart failure.The detection of three can effectively reflect the pathological changes,and is an effective index for the diagnosis and evaluation of heart failure.
作者 杜鹏 彭耀中 DU Peng;PENG Yaozhong(Department of Clinical Laboratory,Huamei Hospital,Liaocheng Second Pople′s Hospital,Liaocheng,Shandong 252600,China)
出处 《国际检验医学杂志》 CAS 2018年第18期2300-2302,2306,共4页 International Journal of Laboratory Medicine
关键词 心力衰竭 肌钙蛋白T 癌抗原125 可溶性ST2 heart failure cTnT CA125 sST2
  • 相关文献

参考文献13

二级参考文献138

  • 1社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3040
  • 2Nunez J, Nunez E, Minana G, et al. Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate anti- gen 125 following a hospitalization for acute heart failure[J]. Eur J Heart Fail, 2012,14(9) :974 - 984.
  • 3Minana EG, Nunez J, Sanchis J, et al. Carbohydrate antigen 125 serial measurements after an admission for acute heart failure and risk of early readmission [J]. Med Clin (Barc),2012,139(11) :479 - 486.
  • 4Nunez J, Sanchis J, Nunez E, et al. Benefits of statin therapy based on plasma carbohydrate antigen 125 values following an admission for acute heart failure [J]. Rev Esp Cardiol,2011,64(12):1100- 1108.
  • 5Nunez J, Nunez E, Sanchis J, et al. Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure[J]. Int J Cardiol,2012,159(1) :21 -28.
  • 6De Gennaro L, Branetti ND, Bungaro R, et al. Carbohydrate antigen-125: additional accuracy in identifying patients at risk of acute heart failure in a- cute coronary syndrome[J]. Coron Artery Dis,2009,20(4):274- 280.
  • 7Ordu S, Ozhan H, Alemdar R, et al. Carbohydrate antigen-125 and N-ter- minal pro- brain natriuretic peptide levels: compared in heact-failure prog- nostication[J]. Tex Heart Inst J,2012,39(1):30- 35.
  • 8Huang F, Chen J, Liu Y, et al. New mechanism of elevated CA125 in heart failure: the mechanical stress and inflammatory stimuli initiate CA125 synthesis[J]. Med Hypotheses,2012,79(3) :381 - 383.
  • 9Braunwald E. Heart failure. JACC Heart Fail, 2013, 1: 1-20.
  • 10McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J, 2012, 33: 1787-1847.

共引文献127

同被引文献39

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部